Tabula Rasa Healthcare Inc. (TRHC)
(Delayed Data from NSDQ)
$55.29 USD
+2.12 (3.99%)
Updated May 3, 2019 04:00 PM ET
After-Market: $55.17 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TRHC 55.29 +2.12(3.99%)
Will TRHC be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TRHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TRHC
Compared to Estimates, Tabula Rasa Healthcare (TRHC) Q2 Earnings: A Look at Key Metrics
Tabula Rasa Healthcare (TRHC) Q2 Earnings and Revenues Surpass Estimates
TRHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Butterfly Network, Inc. (BFLY) Reports Q2 Loss, Tops Revenue Estimates
Tabula Rasa Healthcare (TRHC) Moves 6.3% Higher: Will This Strength Last?
Tabula Rasa Healthcare (TRHC) Surges 7.8%: Is This an Indication of Further Gains?